Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function

BACKGROUND/AIMS: Treatment of chronic hepatitis C virus (HCV) infection in patients with chronic kidney disease (CKD) is essential. The availability of sofosbuvir (SOF) has dramatically improved overall HCV cure rates, however there is insufficient data regarding its use in patients with CKD. We eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hyun Phil, Park, Ji-Ae, Burman, Blaire, Kozarek, Richard A., Siddique, Asma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760003/
https://www.ncbi.nlm.nih.gov/pubmed/28827512
http://dx.doi.org/10.3350/cmh.2016.0087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760003/
https://www.ncbi.nlm.nih.gov/pubmed/28827512
http://dx.doi.org/10.3350/cmh.2016.0087

Ejemplares similares